Simple signs could signal complex pain syndrome
GLASGOW – Two novel clinical signs can be used to determine whether people who have had a fracture are likely to develop complex regional pain syndrome, a condition for which there is currently no... (Source: Clinical Neurology News)
Source: Clinical Neurology News - May 9, 2016 Category: Neurology Source Type: news

I Feel Your Pain: The Power of Witness in Group Support
People have a deeply innate desire to be seen. I'm not talking about Facebook selfie type visibility, I mean really be seen. To have people, or even that one person, be tuned-in to your joy, struggle or other experience. To simply be present without trying to fix you. When somebody bears witness to a piece of my story, we've established a connection and those shared moments become a part of me. I have received a valuable gift. To be witness to the story of another is also powerful. Even though deep down we want people to see who we are, we might be conflicted about that. It can feel vulnerable, uncomfortable or even un...
Source: Healthy Living - The Huffington Post - April 28, 2016 Category: Consumer Health News Source Type: news

MassDevice.com +5 | The top 5 medtech stories for April 11, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Grifols puts up $100m for a 49% stake in Interstate Blood Bank Grifols said that it agreed to pay $100 million for a 49% stake in plasma collector Interstate Blood Bank. The deal includes an option to buy the remaining 51% for ...
Source: Mass Device - April 11, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

St. Jude Medical’s Axium chronic pain device makes its U.S. debut
St. Jude Medical (NYSE:STJ) today announced the U.S. debut of its Axium neurostimulator system, after the device won FDA approval in February for treating chronic pain. The 1st patients were implanted in West Virginia and California with the Axium device, which uses dorsal root ganglion stimulation to treat moderate to severe chronic intractable pain of the lower limbs in adult patients with complex regional pain syndrome, St. Jude said. The Axium is slated to be implanted in 25 states in the coming weeks, with 100 procedures due in the 1st month after launch, the Little Canada, Minn.-based company said. “Si...
Source: Mass Device - April 11, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Neuromodulation/Neurostimulation Pain Management Wall Street Beat St. Jude Medical Source Type: news

St. Jude Medical Announces US Launch and First Commercial Implants of DRG Stimulation Therapy
Availability of the dorsal root ganglion (DRG) therapy represents an important milestone in the treatment of chronic intractable pain conditions due to complex regional pain syndrome I and II ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. ... Devices, Neurology, Product LaunchSt. Jude Medical, dorsal root ganglion, Axium , Neurostimulator, DRG therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 11, 2016 Category: Pharmaceuticals Source Type: news

St. Jude wins FDA green light for Axium chronic pain device
St. Jude Medical (NYSE:STJ) said today it won FDA premarket approval for its Axium neurostimulator system using dorsal root ganglion stimulation. The device from St. Paul, Minn.-based St. Jude is designed to treat moderate to severe chronic intractable pain of the lower limbs in adult patients with complex regional pain syndrome. “The approval of St. Jude Medical’s DRG neurostimulation system represents an exciting new option for me to deploy in the fight against the focal and intractable chronic pain syndromes facing my patients every day. For the large and growing numbers of under-treated patients suffering fro...
Source: Mass Device - February 17, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Neurological Neuromodulation/Neurostimulation St. Jude Medical Source Type: news

EU agency finds syndromes not caused by HPV vaccine
Stephen FellerLYON, France, Nov. 5 (UPI) -- A European agency found no link between the HPV vaccine and the development of complex regional pain syndrome or postural orthostatic tachycardia syndrom. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 5, 2015 Category: Consumer Health News Source Type: news

EU regulator finds no safety issues with GSK, Merck HPV vaccines
LONDON (Reuters) - European drug regulators have found no safety concerns linking GlaxoSmithKline's and Merck's cervical cancer vaccines with two conditions known as complex regional pain syndrome (CRPS) and postural orthostatic tachycardia syndrome (POTS). (Source: Reuters: Health)
Source: Reuters: Health - November 5, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Unexpected link between choroid plexus, chronic pain
Neuroscientists have found a novel connection between the size of the choroid plexus in the brain and complex regional pain syndrome (CRPS), an unexpected finding, they say. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 22, 2015 Category: Science Source Type: news

St. Jude Study: Axium Neurostimulator Outperforms Traditional Spinal Cord Stimulators
St. Jude Medical is touting positive results of a clinical trial that demonstrated the effectiveness of its Axium Neurostimulator System over traditional spinal cord stimulators (SCS) to relieve the chronic lower limb pain associated with complex regional pain syndrome (CRPS) or peripheral causalgia (nerve damage). The Axium system stimulates the dorsal root ganglion (DRG) for more selective targeting of pain areas that are hard to reach, like the groin, lower leg, and foot. (Source: Medical Design Online News)
Source: Medical Design Online News - June 12, 2015 Category: Medical Equipment Source Type: news

St. Jude Medical touts early results for Axium neurostim device
St. Jude Medical (NYSE:STJ) said Monday that a study of its Axium dorsal root ganglion neurostimulator showed superior pain relief compared to traditional spinal cord stimulation in treating chronic lower limb pain associated with complex regional pain syndrome. The the 152-patient Accurate study reported that 81.2% of patients treated with the Axium system achieved significant pain relief, compared to 55.7% treated with traditional SCS, St. Paul, Minn.-based St. Jude said. Patients also reported less posture-based paresthesia intensity with DRG, and were less likely to report stimulation outside the area of pain, the com...
Source: Mass Device - June 10, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Implants Neuromodulation/Neurostimulation Pain Management Spinal St. Jude Medical Source Type: news

Complex regional pain syndrome in a patient with acute drug poisoning: a case report - Hiraiwa T, Okada H, Sawada N, Nakayama K, Senda N, Kawanishi M.
We report a case with transition to complex regional pain syndrome (CRPS) caused by nerve injury associated with crush syndrome. The diagnosis was delayed because of coma due to acute drug poisoning. A 44-year-old man had attempted suicide by taking massiv... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - March 26, 2015 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

Causes of serious pain syndrome closer to discovery
A major step forward has been made in understanding the causes of a disorder which causes chronic pain in sufferers. Complex Regional Pain Syndrome (CRPS) is a serious condition affecting a limb after an -- often small -- accident or operation. It can cause severe pain lasting many years, as well as limb swelling, hair and nail growth changes, and muscle atrophy, but until now there has been no clear evidence of the cause. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 2, 2014 Category: Science Source Type: news

What Causes Leg Pain?
Discussion “Growing pains” of the legs are a common complaint in children. Heterogeneous studies from 1928-2004 have found prevalence rates of 2.6-49.4% in children ages 4-19. The studies are heterogeneous because of time, location, and especially definition of growing pains. A study of 1445, 4-6 year olds in 2004 using a validated tool showed a prevalence rate of 36.9%. The definition of growing pains used by Peterson in the 2004 study is chronic “…intermittent (nonarticular) pains in both legs that generally occur late in the day or at night…” with a normal physical examination and l...
Source: PediatricEducation.org - May 19, 2014 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Tortured by pain doctors can't explain? Complex regional pain syndrome may be why
GP Dr Nick Mann from Hackney, East London, had shoulder-hand syndrome - a form of complex regional pain syndrome (CRPS). (Source: the Mail online | Health)
Source: the Mail online | Health - May 13, 2014 Category: Consumer Health News Source Type: news